| RS1800366 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS1800367831 |
ASAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, Farber lipogranulomatosis |
| RS1800369 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1800371 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1800379 |
VWF
|
Health Risk |
Pathogenic |
— |
| RS1800386 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity; risk factor |
Hereditary von Willebrand disease, Inborn genetic diseases |
| RS1800386420 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS1800408 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Inborn genetic diseases |
| RS1800409 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS1800418 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS1800421 |
TYR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism, Oculocutaneous albinism |
| RS1800427 |
PAX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1800450 |
MBL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mannose-binding lectin deficiency, Mannose-binding lectin deficiency |
| RS1800456 |
OAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine aminotransferase deficiency, Ovarian serous cystadenocarcinoma |
| RS1800463 |
SERPINA3
|
Health Risk |
Pathogenic |
ANTICHYMOTRYPSIN BOCHUM 1, ANTICHYMOTRYPSIN BOCHUM 1 |
| RS1800466 |
MAOA
|
Health Risk |
Conflicting classifications of pathogenicity |
Brunner syndrome, Inborn genetic diseases |
| RS1800467 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS1800480 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1800492946 |
RUNX2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS1800496 |
DRD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonic disorder, DRD2-associated Dystonia |
| RS1800500908 |
BRAF
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 1, Cardiofaciocutaneous syndrome 1 |
| RS1800507644 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, 6 conditions |
| RS1800519 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS1800540581 |
EYA4
|
Health Risk |
Pathogenic |
— |
| RS1800546 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, See cases |
| RS1800548 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Stargardt disease |
| RS1800549 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCA4-related disorder, Retinal dystrophy |
| RS1800552 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Inborn genetic diseases |
| RS1800553 |
ABCA4
|
Health Risk |
Pathogenic |
MACULAR DEGENERATION, AGE-RELATED |
| RS1800557 |
APP
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease, Alzheimer disease |
| RS1800558 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1800562 |
HFE
|
Health Risk |
Conflicting classifications of pathogenicity; other; risk factor |
Hemochromatosis type 1, Hereditary cancer-predisposing syndrome |
| RS1800565 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS1800575 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Type 2 diabetes mellitus |
| RS1800576 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly, Atypical hemolytic-uremic syndrome |
| RS1800578 |
THBD
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with thrombomodulin anomaly, Atypical hemolytic-uremic syndrome |
| RS1800582 |
GYPA
|
Health Risk |
Pathogenic |
BLOOD GROUP ERIK, BLOOD GROUP ERIK |
| RS1800586 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1800588 |
LIPC
|
Health Risk |
association |
High density lipoprotein cholesterol level quantitative trait locus 12, High density lipoprotein cholesterol level quantitative trait locus 12 |
| RS1800704 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1800727 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1800728 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 3, Retinal dystrophy |
| RS1800728912 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1800730 |
HFE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hemochromatosis type 1, Hereditary hemochromatosis |
| RS1800747 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1800750 |
TNF
|
Health Risk |
risk factor |
Malaria, cerebral |
| RS1800751 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1800757 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1800795 |
IL6
|
Health Risk |
other; risk factor |
Crohn disease-associated growth failure, susceptibility to |
| RS1800807147 |
CNTNAP2
|
Health Risk |
Pathogenic |
— |
| RS1800843840 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1800848418 |
COG5
|
Health Risk |
Likely pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1800848531 |
COG5
|
Health Risk |
Likely pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS1800853 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, permanent neonatal 3 |
| RS1800857447 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1800859 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS1800890010 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1800896 |
IL10
|
Health Risk |
Pathogenic |
Leprosy, susceptibility to |
| RS1800897309 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1800904262 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1800908907 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1800911222 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS1800917478 |
STAG3
|
Health Risk |
Likely pathogenic |
Premature ovarian failure 8, Premature ovarian failure 8 |
| RS1800925 |
IL13
|
Health Risk |
risk factor |
Inherited susceptibility to asthma, Inherited susceptibility to asthma |
| RS1800925762 |
BBS12
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 12, Bardet-Biedl syndrome 12 |
| RS1800926856 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1800928352 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1800928868 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1800930 |
IL36RN
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized pustular psoriasis, Acrodermatitis continua suppurativa of Hallopeau |
| RS1800931751 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1800933874 |
BBS12
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1800936242 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1800937 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1800937691 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac arrhythmia, Cardiovascular phenotype |
| RS1800940404 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Cardiac arrhythmia |
| RS1800946921 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1800949012 |
KCNH2
|
Health Risk |
Pathogenic |
— |
| RS1800949572 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 2, Long QT syndrome |
| RS1800955 |
-
|
Health Risk |
Uncertain risk allele |
methamphetamine use disorder, methamphetamine use disorder |
| RS1800955789 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1800956 |
ENG
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemorrhagic telangiectasia, Telangiectasia |
| RS1800958758 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome 2 |
| RS1800970116 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1800975855 |
KCNH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiac arrhythmia, Cardiovascular phenotype |
| RS1800995 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1801002 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 1A, Hearing impairment |
| RS1801002279 |
KCNH2
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 26, Hypertrophic cardiomyopathy 26 |
| RS1801005389 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS1801007403 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801008727 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801030116 |
BRAF
|
Health Risk |
Pathogenic |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS1801032151 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801084514 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome 2 |
| RS1801085857 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome 2 |
| RS1801086 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1801088980 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801134712 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801136288 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1801136696 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS1801137678 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome, Long QT syndrome |